46 Woodstock Road,
Oxford, OX2 6HT
Non-Executive Director
Andre is a hugely experienced Deep Tech advisor with an extensive background in investment banking.
Previously, Andre was Managing Director, Global Head of Equity Trading at Deutsche Bank. He left investment banking in 2016 and founded Braavos Partners, an early- to growth-stage venture capital firm.
He currently sits on the Board of South African biotech company Next Biosciences, and was previously on the Boards of Deep Science Ventures, Sygnia Asset Management and Genesis Genetics.
He’s brought all this experience to the board at Oxford Science Enterprises since he joined in early 2020.

Oxford researchers & innovators
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.

Investors
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.

Co-investors
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.